SAN DIEGO–(BUSINESS WIRE)–$AMRS #Amyris—Haeggquist & Eck, LLP, a leading shareholder rights litigation firm, is investigating whether certain directors and officers of Amyris, Inc. (“Amyris” or the “Company”) (NASDAQ: AMRS) breached their fiduciary duties to the Company and its shareholders. If you are an Amyris shareholder, you are encouraged to contact Amber Eck at Haeggquist & Eck for additional information.
Amyris is an industrial biotech company that develops and produces chemical ingredients, including flavors and fragrance, cosmetics ingredients, pharmaceuticals, and nutraceuticals.
On April 11, 2019, Amyris filed a form 8-K with the SEC announcing that it would be restating its financial results for the period ending March 31, 2018 through September 30, 2018. Amyris attributed the restatement to material errors made in connection with its revenue recognition practices, expenses, and certain foreign currency transactions. On this news, its stock dropped $1.51, or approximately 39% from its April 10, 2019 trading price.
Haeggquist & Eck is investigating whether Amyris and its officers and directors made, or allowed Amyris to make, false and/or misleading statements to investors, and whether they breached their fiduciary duties by failing to maintain adequate internal controls over Amyris’ operations and financial reporting.
What You Can Do
If you are an Amyris shareholder, you may have legal claims against its directors and officers. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Amber Eck at 619-342-8000 or e-mail her at [email protected]. There is no cost or obligation to you.
Haeggquist & Eck, LLP is a nationally recognized leader in shareholder rights law. The firm represents individual investors in shareholder derivative lawsuits, and members of the firm have helped shareholders recover more than $1 billion of value for themselves and the companies in which they have invested.
This release constitutes attorney advertising. Past results do not guarantee a similar outcome.
Contacts
Haeggquist & Eck, LLP
619-342-8000
Amber Eck, [email protected]
